Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.
D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D001792:Blood Platelets / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000008:administration & dosage / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005753:Gastric Mucosa / Q000187:drug effects; D006801:Humans; D013442:Sulfinpyrazone / Q000008:administration & dosage / Q000009:adverse effects
D005343:Fibrinolytic Agents; D004176:Dipyridamole; D011464:Epoprostenol; D001241:Aspirin; D013442:Sulfinpyrazone